Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The reporting lines that hold up under a state survey and a PE diligence call
A defensible behavioral health org structure separates clinical authority (Medical Director, Clinical Director) from operational authority (CEO/COO, Admissions, RCM, HR, Facilities) and keeps the Compliance Officer, Privacy Officer, and QAPI chair reporting directly to the governing body with a dotted line to the CEO. That design is not a preference. It is what 42 CFR Part 8 implies for OTPs certified by SAMHSA and registered with the DEA, what state single state agencies expect for SUD licensure, and what The Joint Commission and CARF surveyors look for when they map authority to accountability.
The 2023 OIG General Compliance Program Guidance made the reporting question explicit. OIG confirms that the Compliance Officer should report either to the CEO with direct access to the board or directly to the board, have equal stature to other senior leaders, and be an advisor to the CEO, the board, and senior leaders on compliance risks facing the company. If your Compliance Officer reports to the CFO or to the COO, you have a structural problem that will surface in a CIA negotiation or a Reps-and-Warranties exclusion. Fix it before a surveyor or a sponsor finds it.
The GCPG also pushed governance further than many operators realize. OIG suggests that large entity Boards consider creating a Board Compliance Committee with a charter to oversee health care compliance separate from audit, finance, or similar committees, and indicates that quality and patient safety oversight should be incorporated into the compliance program. That means QAPI is not a side project owned by the Clinical Director. The governing body owns it.
Clinical authority vs. Operational authority: why the split matters
The Medical Director owns medical necessity, medication-assisted treatment protocols, physician supervision of mid-levels, and sign-off on ASAM Criteria 4th Edition level-of-care decisions. The Clinical Director owns the clinical program, counselor supervision, group curriculum, and documentation standards. Those are two jobs. In small startups I often see one physician wearing both hats on paper, and it survives initial licensure. It does not survive a Joint Commission survey window or a payer SIU audit once census grows past roughly 40 patients across multiple levels of care.
Operational authority sits with the CEO and COO and covers admissions, utilization management, RCM, HR, IT, EOC, and facilities. Keep clinical judgment out of RCM, and keep RCM out of clinical judgment. The segregation of duties is not optional for programs handling 42 CFR Part 2 records, because the consent-and-disclosure logic requires a clear line between who holds the clinical record and who releases it.
Staffing those boxes is the hard part. HRSA projections indicate demand for behavioral health services will increase by 49% through 2033, while workforce supply is projected to grow by only 11% over the same period. HRSA’s December 2025 projections show 2038 shortages of 99,840 psychologists, 99,780 mental health counselors, 77,050 addiction counselors and 43,810 psychiatrists in full-time equivalents. If your Florida or North Carolina pro forma assumes you will hire an LCSW clinical supervisor within 60 days of signing the lease at a $95,000 to $115,000 fully loaded cost, rebuild it. The posted rate in those markets is running closer to $135,000 once you add benefits, licensure maintenance, and sign-on, and the time-to-fill is north of 90 days.
Compliance, QAPI, and the governing body: the three-lane highway
Picture three lanes running from the floor to the board. Lane one is clinical, running up through the Clinical Director to the Medical Director to a Clinical Quality Committee of the board. Lane two is operational, running up through department heads to the COO to the CEO to the full board. Lane three is compliance and QAPI, running from the Compliance Officer, Privacy Officer, HIPAA Security Officer, and QAPI chair up to a Board Compliance Committee. Lane three does not get filtered through the CEO.
OIG is specific about what the board is supposed to do in that third lane. The board compliance committee should actively oversee the compliance program function, evaluate the risk assessment process, and reserve time at each meeting to discuss the compliance program, activities, and risk updates with the Chief Compliance Officer. If your board minutes do not show a standing compliance agenda item with the CCO present, an OCR investigator or a plaintiff’s attorney will notice. HHS OCR civil monetary penalties for HIPAA violations in the willful-neglect tier currently run up to $71,162 per violation with an annual cap of $2,134,831 per identical requirement. A board that cannot show it oversaw the compliance function is the one that writes that check.
This lane also matters because Medicaid pays for most of what behavioral health operators do. Medicaid accounted for 25% of all spending on mental health services and 21% of all spending on SUD services in 2014, making it one of the largest financing sources. State Medicaid agencies and MCOs expect a Compliance Officer with authority to halt billing. If that authority is buried two levels under the CFO, you cannot stop the clock when you need to.
Multi-state, multi-site, and the MSO layer PE sponsors want to see
Once you cross the first state line, the org chart has to answer a question every sponsor asks in diligence: what is corporate, what is facility, and what sits in the MSO? The clean answer separates clinical governance (which lives inside each licensed entity under the state SSA) from shared services (RCM, credentialing, IT, HR, compliance program administration, QAPI tooling) that sit at the MSO. The Medical Director at each site is the license holder of record. The corporate Chief Medical Officer sets clinical policy but does not override a state-licensed Medical Director’s clinical decisions.
PE sponsors also want governance that survives a hold period and an exit. OIG suggests that large entity Boards consider creating a Board Compliance Committee with a charter to oversee health care compliance separate from audit, finance, or similar committees. That same committee structure is what a strategic buyer’s QofE team looks for. On a platform transacting in the 8x to 11x adjusted EBITDA range, a governance gap that triggers a Reg S-K style disclosure exclusion can cost you a full turn of multiple before you ever get to the purchase agreement. Build the committee on day one of the platform, not the week before the data room opens.
A few practical notes from the Montana, North Carolina, Florida, and Texas platforms we work with. One, OTPs certified under 42 CFR Part 8 require a Program Sponsor and a Medical Director named to SAMHSA, and adding an OTP to an existing SUD platform forces you to add DEA registration, diversion control, and dedicated supervision that does not fit under a general Clinical Director. Two, if you add Joint Commission accreditation to a CARF-accredited platform, the Behavioral Health Care manual’s leadership chapter will force you to reconcile titles and reporting lines you had let drift, and plan on $35,000 to $60,000 in direct survey and application fees plus a six to nine month runway before the initial survey. Three, if you operate across SSAs, do not create one corporate policy library and assume it maps. Map state-by-state and version-control the delta.
Frequently asked questions
Who should the Compliance Officer report to in a behavioral health company?
The Compliance Officer should report to the CEO with direct access to the board, or directly to the board, and hold equal stature to other senior leaders. Reporting to the CFO or General Counsel is a structural red flag that OIG and most PE sponsors will flag.
Can the Medical Director also serve as the Clinical Director?
In a very small single-site startup, yes, but it rarely holds past initial licensure. Once you add a second level of care, a second site, or OTP services under 42 CFR Part 8, separate the roles. A single person wearing both hats creates documentation, supervision, and payer-credentialing conflicts that surveyors catch.
What org structure changes are required when adding an OTP or Joint Commission accreditation?
Adding an OTP requires a named Program Sponsor, a Medical Director registered with SAMHSA and the DEA, a diversion control plan, and dedicated nursing and pharmacy oversight that sits outside the general counseling program. Adding Joint Commission on top of state licensure forces you to align leadership titles, written scope-of-authority documents, QAPI cadence, and EOC ownership with the Behavioral Health Care accreditation manual’s leadership standards, typically a 6 to 9 month build.
How should a multi-state behavioral health platform structure corporate vs. Facility-level leadership?
Clinical authority (Medical Director, Clinical Director) lives at the licensed facility level under the state single state agency. Shared services (RCM, credentialing, IT, HR, compliance administration, payer contracting, QAPI analytics) sit at the MSO. Corporate CMO and Chief Compliance Officer set policy and audit against it. They do not override a state-licensed clinician’s individual clinical judgment.
What governance structure do PE sponsors expect post-acquisition?
A board with a dedicated Compliance Committee separate from audit, a Chief Compliance Officer with direct board access and quarterly executive sessions, a Chief Medical Officer independent of the CEO, documented QAPI tied to board reporting, and a management services agreement that cleanly separates corporate from clinical decision-making. Sponsors increasingly ask for this on the first 100-day plan, not at exit.
References
- HHS-OIG General Compliance Program Guidance (November 2023)
- 42 CFR Part 8: Medication Assisted Treatment for Opioid Use Disorders
- 42 CFR Part 2: Confidentiality of Substance Use Disorder Patient Records
- HRSA National Center for Health Workforce Analysis: Behavioral Health Workforce Projections
- KFF: Medicaid’s Role in Financing Behavioral Health Services
- The Joint Commission: Behavioral Health Care and Human Services Accreditation
- CARF International: Behavioral Health Standards
- SAMHSA TIP 52: Clinical Supervision and Professional Development of the Substance Abuse Counselor